These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35060324)
1. Comparative analysis of three serum-free light-chain detection systems in the diagnosis of multiple myeloma. Zhu G; Fu X; Ren Y; Wang Y; Wang S; An G Int J Lab Hematol; 2022 Jun; 44(3):576-581. PubMed ID: 35060324 [TBL] [Abstract][Full Text] [Related]
2. [Two Serum Free Light Chain Detection Systems in the Diagnosis of Multiple Myeloma]. Zhu GQ; Fu X; Ren YS; Wang YS; Wang SL; Wang LC; Lin J; An G Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1209-1215. PubMed ID: 34362504 [TBL] [Abstract][Full Text] [Related]
3. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains. Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834 [TBL] [Abstract][Full Text] [Related]
4. Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers. Yun SY; Rim JH; Park H; Kang H; Lee SG; Lim JB Clin Chem Lab Med; 2023 Jun; 61(7):1288-1299. PubMed ID: 37015073 [TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of serum free light chains measurement in patients with multiple myeloma: comparative analysis of two different tests. Kubicki T; Dytfeld D; Baszczuk A; Wysocka E; Komarnicki M; Lewandowski K Postepy Hig Med Dosw (Online); 2017 Jan; 71(0):40-46. PubMed ID: 28181910 [TBL] [Abstract][Full Text] [Related]
6. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory. Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753 [TBL] [Abstract][Full Text] [Related]
7. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study. Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308 [TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the Diagnostic Value of sFLC and Other Indicators in the Detection of M Protein in LCMM. Wang J; Zhao Y; Ren Z; Sun A; Huang Z; Li X Clin Lab; 2023 Oct; 69(10):. PubMed ID: 37844061 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System]. Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604 [TBL] [Abstract][Full Text] [Related]
11. Effects of Long-Term Storage on Serum Free Light Chain Stability. Hörber S; Klein R; Peter A Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238 [TBL] [Abstract][Full Text] [Related]
12. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser. Maisin D; Lepoutre T; Gruson D; Wallemacq P Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572 [TBL] [Abstract][Full Text] [Related]
14. The association of serum-free light-chain levels with markers of renal function. Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734 [TBL] [Abstract][Full Text] [Related]
15. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population. Liang YF; Chen WM; Wang QT; Zhai YH; Yang YJ; Liu JY; Levoguer A; Sun WH Clin Lab; 2014; 60(2):193-8. PubMed ID: 24660530 [TBL] [Abstract][Full Text] [Related]
16. Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment. Rollborn N; Jakobsson J; Campbell A; Nordin G; Karlsson M; Larsson A; Kultima K Clin Biochem; 2023 Jan; 111():47-53. PubMed ID: 36241061 [TBL] [Abstract][Full Text] [Related]
17. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer. Augustijn D; Jacobs JFM; Russcher H Clin Chem Lab Med; 2022 Feb; 60(3):379-385. PubMed ID: 34969184 [TBL] [Abstract][Full Text] [Related]
18. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920 [TBL] [Abstract][Full Text] [Related]
19. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG; Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545 [TBL] [Abstract][Full Text] [Related]
20. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]